1. Home
  2. INDP vs VEEE Comparison

INDP vs VEEE Comparison

Compare INDP & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • VEEE
  • Stock Information
  • Founded
  • INDP 2000
  • VEEE 1994
  • Country
  • INDP United States
  • VEEE United States
  • Employees
  • INDP N/A
  • VEEE N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • VEEE Marine Transportation
  • Sector
  • INDP Health Care
  • VEEE Industrials
  • Exchange
  • INDP Nasdaq
  • VEEE Nasdaq
  • Market Cap
  • INDP 6.0M
  • VEEE 5.8M
  • IPO Year
  • INDP N/A
  • VEEE 2021
  • Fundamental
  • Price
  • INDP $2.40
  • VEEE $2.56
  • Analyst Decision
  • INDP Strong Buy
  • VEEE
  • Analyst Count
  • INDP 2
  • VEEE 0
  • Target Price
  • INDP $238.00
  • VEEE N/A
  • AVG Volume (30 Days)
  • INDP 77.0K
  • VEEE 4.4M
  • Earning Date
  • INDP 08-13-2025
  • VEEE 08-07-2025
  • Dividend Yield
  • INDP N/A
  • VEEE N/A
  • EPS Growth
  • INDP N/A
  • VEEE N/A
  • EPS
  • INDP N/A
  • VEEE N/A
  • Revenue
  • INDP N/A
  • VEEE $13,153,262.00
  • Revenue This Year
  • INDP N/A
  • VEEE N/A
  • Revenue Next Year
  • INDP N/A
  • VEEE N/A
  • P/E Ratio
  • INDP N/A
  • VEEE N/A
  • Revenue Growth
  • INDP N/A
  • VEEE N/A
  • 52 Week Low
  • INDP $2.47
  • VEEE $1.86
  • 52 Week High
  • INDP $58.24
  • VEEE $9.30
  • Technical
  • Relative Strength Index (RSI)
  • INDP 18.11
  • VEEE 58.40
  • Support Level
  • INDP $6.26
  • VEEE $2.24
  • Resistance Level
  • INDP $6.65
  • VEEE $3.46
  • Average True Range (ATR)
  • INDP 0.69
  • VEEE 0.30
  • MACD
  • INDP -0.33
  • VEEE 0.06
  • Stochastic Oscillator
  • INDP 1.86
  • VEEE 44.37

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About VEEE Twin Vee PowerCats Co.

Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.

Share on Social Networks: